64 studies found for:    Open Studies | "Cytomegalovirus Infections"
Show Display Options
Rank Status Study
21 Recruiting Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Condition: Cytomegalovirus Infections
Interventions: Drug: VBI-1501A;   Drug: VBI-1501;   Drug: Placebo
22 Unknown  The Link Between Human Cytomegalovirus (HCMV) and Hypertension
Conditions: HCMV Infection;   Hypertension
Intervention:
23 Unknown  Genotyping of Cytomegalovirus From Patients in Israel
Condition: Cytomegalovirus Infections
Intervention:
24 Recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
Condition: CMV Infections
Intervention: Biological: Viralym-C
25 Unknown  Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Condition: Cytomegalovirus Congenital Infection
Intervention: Biological: standard intravenous immunoglobulin
26 Recruiting Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
Condition: Cytomegalovirus Infection
Interventions: Biological: Low dose HB-101;   Biological: Medium dose HB-101;   Biological: High dose HB-101;   Biological: Placebo
27 Recruiting Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
Condition: Cytomegalovirus Infection
Interventions: Drug: MBX400;   Other: Placebo
28 Recruiting Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients
Conditions: Cytomegalovirus Infection;   GVHD
Intervention:
29 Recruiting Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Conditions: Sensorineural Hearing Loss;   Cytomegalovirus Infection
Intervention:
30 Recruiting Biochip for HCMV Detection in Breast Milk
Conditions: Cytomegalovirus Infections;   Breast Feeding;   Premature Birth of Newborn
Intervention:
31 Recruiting Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis
Conditions: Ulcerative Colitis;   Cytomegalovirus Infections;   Disease Exacerbation
Intervention:
32 Not yet recruiting Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection
Condition: Cytomegalovirus Infections
Intervention: Biological: IFN-γ positive selected T-cells
33 Recruiting A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
Conditions: Adenovirus Infection;   EBV;   Cytomegalovirus Infections;   Cytokine Capture System®;   Allogenic Disease
Intervention: Biological: IFN-γ positive selected T-cells
34 Recruiting ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Conditions: Transplantation Infection;   Epstein-Barr Virus Infections;   Cytomegalovirus Infections
Interventions: Drug: Valacyclovir;   Drug: Valganciclovir
35 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
36 Recruiting Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV Specific T Cell donor lymphocyte infusion
37 Unknown  Cytomegalovirus (CMV) Infection in Amniotic Fluid
Conditions: Pregnancy Complications;   Cytomegalovirus Infections
Intervention:
38 Recruiting An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Condition: Cytomegalovirus Infections, Transplantation
Intervention:
39 Recruiting Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Condition: Congenital Cytomegalovirus Infection
Interventions: Drug: Valacyclovir;   Drug: Placebo
40 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years